Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Soc Sci Med. 2012 Aug 25;80:130–140. doi: 10.1016/j.socscimed.2012.08.011

Figure 1. Participant Screening, Enrollment, and Follow-Up Completion*.

Figure 1

*Participants withdrawn between the 3, 6, and 9 month follow-up were withdrawn by the PI due to no longer meeting inclusion criteria. Across groups, the primary reasons for withdrawal included becoming pregnant (14.6% of withdrawn participants), moved from area (52%), and other (33.3%). Reasons for withdrawal were distributed evenly across groups. Participants withdrawn for the study were not allowed to re-enter the study at a later time point; however, it was not uncommon for participants to miss an early follow-up visit and return for a subsequent follow-up. Of the 373 women eligible to complete the 9 month follow-up (i.e., those who were not withdrawn from the study - 188 in the CG, and 185 in the IG), 76% completed the final follow-up visit (n=285).